ArteraAI

ArteraAI

One-liner: “ArteraAI develops AI tests for personalized cancer therapy, focusing on prostate cancer treatment for healthcare providers and patients.”

Company slogan: “A leading precision medicine company, Artera develops AI-enabled tests to help personalize therapy for cancer patients.”

Positioning: “ArteraAI is positioned as a pioneer in personalized cancer therapy through the use of multimodal AI tests, specifically targeting prostate cancer treatment.”

Description: Our AI can prognosticate patient outcomes & personalize treatment in localized prostate cancer.

Five Phase III randomized trials were used to develop prognostic and predictive AI biomarkers.

Employees: 108

Website: Visit website

Headquarters: “Los Altos, California”

Ownership: Privately Held

Founded:

Company type: AI company

Use cases: “AI in cancer therapy, personalized medicine, prostate cancer treatment”

Pricing: CMS payment rate established for ArteraAI prostate cancer test

Client sector: healthcare

Business model: subscription

Products: ArteraAI Prostate Test

Is API available: no

Website title: Arteria AI

Website description: Discover the power of Personalized Precision Medicine & AI Cancer Therapy with Artera. Transforming cancer therapy through innovation.

Linkedin: https://www.linkedin.com/company/arteraai

Youtube:

Instagram:

Facebook:

Twitter: https://twitter.com/arteraAI

Crunchbase: https://www.crunchbase.com/organization/artera-98e6

Email: